SAMANTHA DEBONE: Open Payments
NPI 1356576987 · CORAOPOLIS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$264 in 7 payments from 6 companies in 2025. Trend: 2023 $2,666 · 2024 $3,267 · 2025 $264
Food & beverage: $264
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $130 |
| UCB, Inc. | 1 | $45 |
| GENZYME CORPORATION | 1 | $28 |
| Janssen Biotech, Inc. | 1 | $26 |
| Amgen Inc. | 1 | $22 |
| Galderma Laboratories, L.P. | 1 | $14 |
Products named: EBGLYSS, Bimzelx, DUPIXENT, TREMFYA, OTEZLA, TALTZ, NEMLUVIO.
Industry payments across PA — which companies pay providers there.
